Halozyme Therapeutics, Inc.
NASDAQ:HALO · NASDAQ Global Select
+$0.56 today
Vol 3.34M · Avg 1.63M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+29.83%
Period High
$81.23
Period Low
$52.02
Latest
$68.55
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Jazz Pharmaceuticals plc
NASDAQ:JAZZ
$14.26B
Cytokinetics, Incorporated
NASDAQ:CYTK
$9.72B
Henry Schein, Inc.
NASDAQ:HSIC
$9.11B
Corcept Therapeutics Incorporated
NASDAQ:CORT
$8.78B
AptarGroup, Inc.
NYSE:ATR
$7.66B
Merus N.V.
MRUS
$6.83B
Rhythm Pharmaceuticals, Inc.
NASDAQ:RYTM
$6.57B
Abivax S.A.
NASDAQ:ABVX
$6.57B
Grifols, S.A.
NASDAQ:GRFS
$6.31B
Caris Life Sciences, Inc.
NASDAQ:CAI
$5.05B
What is the latest HALO filing?
The latest filing shown is 4 dated Jun 15, 2026.
How many recent filings does HALO have?
Intrinsic Alpha currently shows 20 recent filings for HALO.
Explore More
Continue the stock analysis
Jump to another research area for this company.